Non-Current Assets
PP&E (Net)
Vertex Pharmaceuticals PP&E (Net) increased by 6.7% to $1.52B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 23.8%, from $1.23B to $1.52B. Over 5 years (FY 2020 to FY 2025), PP&E (Net) shows an upward trend with a 9.7% CAGR.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ3 2015
Last reportedQ4 2025
How to read this metric
An increase indicates investment in future capacity or infrastructure, while a decrease suggests asset aging or a shift toward an asset-light model.
Detailed definition
The book value of long-term physical assets such as manufacturing facilities, data centers, and retail stores, net of ac...
Peer comparison
Varies significantly based on whether a company owns its manufacturing plants or outsources production to third-party partners.
Metric ID:
property_plant_equipment_netHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.02B | $1.04B | $1.09B | $1.11B | $1.10B | $1.12B | $1.11B | $1.11B | $1.12B | $1.12B | $1.16B | $1.17B | $1.20B | $1.12B | $1.23B | $1.30B | $1.34B | $1.43B | $1.52B |
| QoQ Change | — | +2.1% | +5.0% | +1.2% | -0.7% | +1.7% | -0.9% | +0.3% | +1.0% | +0.1% | +3.1% | +1.2% | +2.4% | -6.9% | +9.8% | +5.5% | +3.0% | +6.7% | +6.7% |
| YoY Change | — | — | — | — | +7.7% | +7.3% | +1.3% | +0.4% | +2.0% | +0.5% | +4.6% | +5.5% | +7.0% | -0.6% | +5.9% | +10.5% | +11.2% | +27.5% | +23.8% |
Range$1.02B – $1.52B
CAGR+9.2%
Avg YoY Growth+7.6%
Median YoY Growth+5.9%
Current Streak5 quarters growth
PP&E (Net) at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's pp&e (net)?
- Vertex Pharmaceuticals (VRTX) reported pp&e (net) of $1.52B in Q4 2025.
- How has Vertex Pharmaceuticals's pp&e (net) changed year-over-year?
- Vertex Pharmaceuticals's pp&e (net) increased by 23.8% year-over-year, from $1.23B to $1.52B.
- What is the long-term trend for Vertex Pharmaceuticals's pp&e (net)?
- Over 5 years (2020 to 2025), Vertex Pharmaceuticals's pp&e (net) has grown at a 9.7% compound annual growth rate (CAGR), from $958.53M to $1.52B.
- What does pp&e (net) mean?
- The value of the company's physical buildings, machinery, and equipment after accounting for wear and tear.